$25M Funding Commitment, Advanced Cell Technology (ACTC.OB)
ACT or ACTC.OB has entered into a $25M non-convertible stock purchase agreement Read more…
ACT or ACTC.OB has entered into a $25M non-convertible stock purchase agreement Read more…
Time flies when you have been having fun or … have we … once a year this is especially evident: by tomorrow, today’s market … will be yesteryear. Read more…
RENE finalized the shareholder approvals necessary to permit the allotment and the issue of the remaining 95,533,498 of the recent placement. Read more…
Case Western Reserve University has received $10M over 5 years to study retinal disease. Read more…
ACTC.OB has entered into a Memorandum of Understanding with Roslin Cells LTD (“Roslin Cells”) of Scotland, Read more…
BTX announced a Material Transfer Agreement (MTA) with the University of California (UC) system Read more…
A Christmas wish is the ideal way to pray for peace for all and better market dynamics. Read more…
ACTC.OB has filed for Orphan Drug Designation with the European Medicines Agency (EMA) for its Retinal Pigment Epithelial (RPE) Cells Read more…
Bob Klein, will continue as the chairman of the oversight board for up to 6 months Read more…

Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.
